 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              Jupiter Bioscience Ltd has announced that the Board of Directors of the Company at its meeting held on May 23, 2007, has decided the following:
1. Allotment of 65,12,470 Equity Shares of Rs 10/- each with a share premium of Rs 143/- per share to the eligible Institutional Buyers in the recently concluded QIP Issue.
2. The Board has passed a resolution that up to 5% of the expanded paid up Equity capital can be allocated for employee stock option plan. This will be in conformity with the relevant guidelines laid down by SEBI and other applicable regulations. It will need to be approved by the shareholders of the Company.
The company has also called for a meeting of the Board of Directors on May 28, 2007, inter alia, to consider and allot Equity Share Warrants to M/s. Ranbaxy Laboratories Ltd.